Literature DB >> 1714657

Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging.

H M Arrighi1, E J Metter, H A Guess, J L Fozzard.   

Abstract

The natural history of prostatism (clinically diagnosed benign prostatic hyperplasia) is examined based on symptom questionnaires and digital rectal examinations administered periodically to 1,057 men followed prospectively for up to thirty years in the Baltimore Longitudinal Study of Aging (BLSA). Benign prostatic hyperplasia (BPH) was clinically diagnosed in 527 men, 110 had a prostatectomy for BPH, and in 21 prostate cancer developed. Among men aged sixty or older with prostatic enlargement and obstructive symptoms, the twenty-year probability of surgery was 39 percent; for men aged fifty to fifty-nine years this probability was 24 percent; and for men aged forty to forty-nine years, the probability was 13 percent. The age-specific prevalence of clinically diagnosed BPH agreed closely at all ages with the age-specific autopsy prevalence of pathologically defined BPH from a published international compilation of 5 independent autopsy studies involving 1,075 prostates.

Entities:  

Mesh:

Year:  1991        PMID: 1714657     DOI: 10.1016/0090-4295(91)80191-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  30 in total

1.  [Urological illnesses in the elderly].

Authors:  J M Wolff
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

Review 2.  Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia: systematic review of randomized controlled trials.

Authors:  Chun Ho Ma; Wai Ling Lin; Sing Leung Lui; Xun-Yuan Cai; Vivian Taam Wong; Eric Ziea; Zhang-Jin Zhang
Journal:  Asian J Androl       Date:  2013-06-03       Impact factor: 3.285

Review 3.  Alpha 1-blockers vs 5 alpha-reductase inhibitors in benign prostatic hyperplasia. A comparative review.

Authors:  J T Andersen
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

Review 4.  [Diagnostics of benign prostate syndrome].

Authors:  M Seitz; A Herlemann; G Magistro; C G Stief
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

5.  [Laservaporization of the prostate: current status of the greenlight and diode laser].

Authors:  M Rieken; A Bachmann; C Gratzke
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

Review 6.  Use of 5alpha-reductase inhibitors to prevent benign prostatic hyperplasia disease.

Authors:  Leonard S Marks
Journal:  Curr Urol Rep       Date:  2006-07       Impact factor: 3.092

Review 7.  Benign prostatic hyperplasia. Practical treatment guidelines.

Authors:  T Tammela
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

Review 8.  Management of non-complicated BPH: proposition of a renewed decision tree.

Authors:  Francois Desgrandchamps; Alexandre de la Taille; Abdel-Rahmène Azzouzi; Marc Fourmarier; Olivier Haillot; Bertrand Lukacs; Christian Saussine
Journal:  World J Urol       Date:  2006-06-21       Impact factor: 4.226

Review 9.  Complications of laser prostatectomy: a review of recent data.

Authors:  Malte Rieken; Nicole Ebinger Mundorff; Gernot Bonkat; Stephen Wyler; Alexander Bachmann
Journal:  World J Urol       Date:  2010-01-06       Impact factor: 4.226

Review 10.  Pelvic ultrasound evaluation for benign prostatic hyperplasia: prediction of obstruction.

Authors:  Daniel B Rukstalis
Journal:  Curr Urol Rep       Date:  2014-05       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.